
FDA approves skin cancer vaccine by...?

Jan 1, 2028
$163.27K Vol.

End date: Jan 1, 2028
Outcomes

June 30, 2027
$20.02K Vol.
34%
34%

September 30, 2027
$9.25K Vol.
43%
43%

December 31, 2027
$134K Vol.
67%
67%
Rules
This market will resolve to "Yes" if the U.S. Food and Drug Administration (FDA) grants approval of intismeran autogene for any indication by December 31, 2027, 11:59 PM ET. Otherwise, this market will resolve to "No".
Comments
Comments